Replies to post #56165 on Enzolytics Inc (ENZC)

[Mutat]

Seems that trials was for HIV not COVID-19. Here is the summary report.
Summarizing the results from the present clinical trial, we can draw the following conclusions:
1. The application of the product ITV-1-lmmunH shows good efficacy in patients with HIV-1 infection in its various stages - in 21 of them (68%) from the main group we note an increase in CD4 + T- lymphocytes; in 16 of them the increase is accompanied by an increase in the index CD4/CD8 and CD4%, which corresponds to a reduction in the immune activation. The increase in these parameters is statistically significant compared to the control group. The absolute number and the relative share of C08 + T lymphocytes is decreasing, too.

[Jmach101]

2014 news article, old out dated many things have happened since that time. You are given it a good college try to make ur point. JMO

[suny66]

Must be in for a great week ahead of us considering the increased bashing going on. Go ENZC

[MikeD]

The article you are referring to is from seven years ago and Zhabilov jr has noted that there are ITV-1 side effects. As I understand currently ITV-1 is being binded with Mabs (from recovered patients) and tested further. Enzolytics has merged with BioClonetics due to new discoveries as per the pr’s.
As of Nov 20 this is interesting research in the field: “Because of ORBIT’s unique structure, Zha and his team have been working to develop a treatment for the coronavirus using antibodies from patients who have recovered from the virus. Through sophisticated technology called single B-cell cloning, the ORBIT team can sort through a recovered patient’s B-cells and identify the antibody that’s matched with the COVID-19 protein.
“The hope is these antibodies can neutralize the virus and prevent it from infecting more normal tissue,” Zha says. Using mouse models, they’ve already identified the COVID-19 target and established the methodology for next steps in the drug’s development.”

https://www.mdanderson.org/cancerwise/monoclonal-antibodies-and-cancer-treatment--what-to-know.h00-159386679.html

[Mistafixit]

Half a decade old report. BioClonetics have found there technology/technique combination with tv-1 creates a synergistic effect for a high efficacy treatment. It has been talked about in many PR's. Might be a little early to call this Garbage stock. Glty

[OTCShotCaller]

Thank you for that!

Now based on what you said, first thing Monday I will ADD another MILLION SHARES to my already HUGH BLOCK of several MILLION!

Thanks!

P.S. on what day of the week do you get paid for your bashing and how much?? $5, just enough to get a McDonalds Happy Meal!

[Dusty18]

"Garbage"? I'm up over 700% and still climbing. Garbage? Sorry you have no shares. Don't take it out on the rest of us.

[Jeff Taitano]

With so much drama on the OTC its kinda hard bein a bear in ENZC, but ahh somehow, someway - people keep comin up with funky ass shit like every single day